Groupe Hospitalier Pitie-Salpetriere

Paris, Île-de-France Region 75013

1 studies enrolling now · 2 studies all time

What they study most

Hematopoietic Stem Cells, Relapsed/Refractory Multiple Myeloma

Studies at this site

• Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1) — Recruiting now
• Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation — Completed